Trial Profile
Postoperative pain treatment following gynecologic surgery, using different doses of transdermal buprenorphine a double – blind, randomized study
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 23 Oct 2012
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 09 Aug 2012 Results published in Current Medical Research and Opinion.
- 19 Apr 2012 Actual end date changed from 4 Feb 2011 to 11 Apr 2011 as reported by EudraCT.
- 15 Mar 2012 Status changed from recruiting to discontinued as reported by EudraCT.